Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression. This is a ...
Encoded Therapeutics Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today will present new preclinical data across ...
Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases, exhibited a ...
Ring Therapeutics ®, a life sciences company pioneering a new class of targeted medicines, today announced new data on its Vector Conjugate platform and VectorBricks™ in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results